Minerva Neurosciences Announces Results Of Dose Escalation Study Evaluating Roluperidone (MIN-101) Administered At Supra-Therapeutic Doses In Healthy Volunteers; Says Doses Up To 256 Miligrams Appear Safe And Will Tolerated
Benzinga Newsdesk